Legal & General Group PLC Ardelyx, Inc. Transaction History
Legal & General Group PLC
- $431 Billion
- Q3 2025
A detailed history of Legal & General Group PLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 269,141 shares of ARDX stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
269,141
Previous 275,344
2.25%
Holding current value
$1.58 Million
Previous $1.08 Million
37.63%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding ARDX
# of Institutions
245Shares Held
161MCall Options Held
697KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA18.4MShares$108 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X013.8MShares$81.1 Million0.04% of portfolio
-
Macquarie Group LTD Australia, C310.5MShares$61.4 Million0.07% of portfolio
-
State Street Corp Boston, MA9.72MShares$57 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $908M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...